110 related articles for article (PubMed ID: 10974631)
21. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
Alexandrie AK; Nyberg F; Warholm M; Rannug A
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
[TBL] [Abstract][Full Text] [Related]
22. The effect of tobacco on lung cancer risk depends on CYP2D6 activity.
Bouchardy C; Benhamou S; Dayer P
Cancer Res; 1996 Jan; 56(2):251-3. PubMed ID: 8542575
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese.
Gao Y; Zhang Q
Mutat Res; 1999 Aug; 444(2):441-9. PubMed ID: 10521684
[TBL] [Abstract][Full Text] [Related]
24. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
Tan W; Chen GF; Xing DY; Song CY; Kadlubar FF; Lin DX
Int J Cancer; 2001 Mar; 95(2):96-101. PubMed ID: 11241319
[TBL] [Abstract][Full Text] [Related]
25. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
26. Effect of genotype and methylation of CYP2D6 on smoking behaviour.
Tiili EM; Antikainen MS; Mitiushkina NV; Sukhovskaya OA; Imyanitov EN; Hirvonen AP
Pharmacogenet Genomics; 2015 Nov; 25(11):531-40. PubMed ID: 26287939
[TBL] [Abstract][Full Text] [Related]
27. CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
Hosono H; Kumondai M; Arai T; Sugimura H; Sasaki T; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):263-8. PubMed ID: 26091970
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
[TBL] [Abstract][Full Text] [Related]
29. Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.
Shaw GL; Weiffenbach B; Falk RT; Frame JN; Issaq HJ; Moir DT; Caporaso N
Lung Cancer; 1997 May; 17(1):61-8. PubMed ID: 9194027
[TBL] [Abstract][Full Text] [Related]
30. The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.
Ouerhani S; Marrakchi R; Bouhaha R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Bull Cancer; 2008 Feb; 95(2):E1-4. PubMed ID: 18304900
[TBL] [Abstract][Full Text] [Related]
31. CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure.
Stücker I; Cosme J; Laurent P; Cenée S; Beaune P; Bignon J; Depierre A; Milleron B; Hémon D
Carcinogenesis; 1995 Nov; 16(11):2759-64. PubMed ID: 7586196
[TBL] [Abstract][Full Text] [Related]
32. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
Yadav SS; Ruwali M; Pant MC; Shukla P; Singh RL; Parmar D
Mutat Res; 2010 Feb; 684(1-2):49-55. PubMed ID: 19954746
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
[TBL] [Abstract][Full Text] [Related]
34. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
Berecz R; de la Rubia A; Dorado P; Fernández-Salguero P; Dahl ML; LLerena A
Eur J Clin Pharmacol; 2003 May; 59(1):45-50. PubMed ID: 12682803
[TBL] [Abstract][Full Text] [Related]
35. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
36. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
37. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
38. [Relation between cytochrome P450 2D6 and lung cancer susceptibility caused by smoking].
Yan Z; Wu Y; Wu Y
Wei Sheng Yan Jiu; 2007 Jan; 36(1):112-3, 116. PubMed ID: 17424863
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
Cui Y; Morgenstern H; Greenland S; Tashkin DP; Mao J; Cao W; Cozen W; Mack TM; Zhang ZF
Int J Cancer; 2006 Feb; 118(3):714-20. PubMed ID: 16094634
[TBL] [Abstract][Full Text] [Related]
40. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
